HomeGlobeNewswire

GlobeNewswire

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

Teva Announces Proposed Acquisition of a Novel Neuroscience Product Reinforcing Disciplined Business Development Approach Under Pivot to Growth Strategy

August 28, 2026

Prospectiva Resources Commences Drilling at the São Francisco Copper-Gold Project

Prospectiva Resources Commences Drilling at the São Francisco Copper-Gold Project

August 28, 2026

G Mining Ventures Announces Normal Course Issuer Bid for Common Shares

G Mining Ventures Announces Normal Course Issuer Bid for Common Shares

August 28, 2026

Avricore Grants Options

Avricore Grants Options

August 28, 2026

MoneyHero Group to Announce Second Quarter 2026 Results

MoneyHero Group to Announce Second Quarter 2026 Results

August 28, 2026

Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine

Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine

August 28, 2026

Issue of Equity and Total Voting Rights

Issue of Equity and Total Voting Rights

August 28, 2026

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Reports Positive Interim Data from Ongoing Phase 2/3 Study of QRX003 in Netherton Syndrome

August 28, 2026

Immuron Reports FY26 Preliminary Results

Immuron Reports FY26 Preliminary Results

August 28, 2026

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

BioXcel Therapeutics Enters Into Asset Sale Agreement with Teva Pharmaceuticals

August 28, 2026

« 1 … 4 5 6 7 8 … 67 »